Thomas E. Hughes's Insider Trades & SAST Disclosures

Thomas E. Hughes's most recent trade in Viridian Therapeutics Inc was a trade of 24,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on May 21, 2020.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Viridian Therapeutics Inc
Thomas E. Hughes Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 May 2020 24,000 24,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades